References

Spatially resolved transcriptomes-next generation tools for tissue exploration

10.1002/bies.201900221 · ExternalCitation · doi-reference

Biomarker qualification: toward a multiple stakeholder framework for biomarker development, regulatory acceptance, and utilization

10.1002/cpt.136 · ExternalCitation · doi-reference

Imaging mass cytometry

10.1002/cyto.a.23053 · ExternalCitation · doi-reference

Ex vivo modeling and pharmacological modulation of tissue immune responses in inflammatory bowel disease using precision-cut intestinal slices

10.1002/eji.70013 · ExternalCitation · doi-reference

Inflammatory bowel disease genomics, transcriptomics, proteomics and metagenomics meet artificial intelligence

10.1002/ueg2.12655 · ExternalCitation · doi-reference

Insights into TL1A and IBD pathogenesis

10.1007/978-1-4419-6612-4_29 · ExternalCitation · doi-reference

Mucosal IL23A expression predicts the response to ustekinumab in inflammatory bowel disease

10.1007/s00535-021-01819-7 · ExternalCitation · doi-reference

An untargeted metabolomic study using MALDI-mass spectrometry imaging reveals region-specific biomarkers associated with bowel inflammation

10.1007/s11306-024-02200-4 · ExternalCitation · doi-reference

Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets

10.1016/j.cell.2015.05.002 · ExternalCitation · doi-reference

Deep profiling of mouse splenic architecture with CODEX multiplexed imaging

10.1016/j.cell.2018.07.010 · ExternalCitation · doi-reference

A structured tumor-immune microenvironment in triple negative breast cancer revealed by multiplexed ion beam imaging

10.1016/j.cell.2018.08.039 · ExternalCitation · doi-reference

Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease

10.1016/j.cell.2018.08.067 · ExternalCitation · doi-reference

Comprehensive integration of single-cell data

10.1016/j.cell.2019.05.031 · ExternalCitation · doi-reference

Intra- and inter-cellular rewiring of the human colon during ulcerative colitis

10.1016/j.cell.2019.06.029 · ExternalCitation · doi-reference

Single-cell analysis of Crohn's disease lesions identifies a pathogenic cellular module associated with resistance to anti-TNF therapy

10.1016/j.cell.2019.08.008 · ExternalCitation · doi-reference

Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways

10.1016/j.cell.2019.10.027 · ExternalCitation · doi-reference

Chromatin potential identified by shared single-cell profiling of RNA and chromatin

10.1016/j.cell.2020.09.056 · ExternalCitation · doi-reference

Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays

10.1016/j.cell.2022.04.003 · ExternalCitation · doi-reference

Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease

10.1016/j.ebiom.2019.01.027 · ExternalCitation · doi-reference

The emerging role of histologic disease activity assessment in ulcerative colitis

10.1016/j.gie.2018.08.018 · ExternalCitation · doi-reference

The enteric network: interactions between the immune and nervous systems of the gut

10.1016/j.immuni.2017.05.011 · ExternalCitation · doi-reference

B cell expansion hinders the stroma-epithelium regenerative cross talk during mucosal healing

10.1016/j.immuni.2022.11.002 · ExternalCitation · doi-reference

The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon

10.1016/j.immuni.2023.01.002 · ExternalCitation · doi-reference

Multi-scaled transcriptomics of chronically inflamed nasal epithelium reveals immune-epithelial dynamics and tissue remodeling in nasal polyp formation

10.1016/j.immuni.2025.08.009 · ExternalCitation · doi-reference

Mechanisms and pathogenesis of chronic rhinosinusitis

10.1016/j.jaci.2022.02.016 · ExternalCitation · doi-reference

Elucidating a myofibroblast-dominated fibrotic niche in Crohn's disease-associated fibrostenosis through high-resolution spatial transcriptomics

10.1016/j.jcmgh.2025.101701 · ExternalCitation · doi-reference

Multimodal single-cell analyses reveal mechanisms of perianal fistula in diverse patients with Crohn's disease

10.1016/j.medj.2024.03.021 · ExternalCitation · doi-reference

Artificial intelligence enables quantitative assessment of ulcerative colitis histology

10.1016/j.modpat.2023.100124 · ExternalCitation · doi-reference

Spatial pharmacology using mass spectrometry imaging

10.1016/j.tips.2023.11.003 · ExternalCitation · doi-reference

Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn's disease

10.1016/j.xcrm.2023.101050 · ExternalCitation · doi-reference

A living organoid biobank of patients with Crohn's disease reveals molecular subtypes for personalized therapeutics

10.1016/j.xcrm.2024.101748 · ExternalCitation · doi-reference

Crohn's disease

10.1016/s0140-6736(16)31711-1 · ExternalCitation · doi-reference

Ulcerative colitis

10.1016/s0140-6736(16)32126-2 · ExternalCitation · doi-reference

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies

10.1016/s0140-6736(17)32448-0 · ExternalCitation · doi-reference

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

10.1016/s0140-6736(17)32641-7 · ExternalCitation · doi-reference

Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

10.1016/s0140-6736(22)00466-4 · ExternalCitation · doi-reference

Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

10.1016/s0140-6736(22)00467-6 · ExternalCitation · doi-reference

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

10.1016/s0140-6736(23)00061-2 · ExternalCitation · doi-reference

Guselkumab in patients with moderately to severely active ulcerative colitis: QUASAR phase 3 induction and maintenance studies

10.1016/s0140-6736(24)01927-5 · ExternalCitation · doi-reference

Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease

10.1016/s2468-1253(18)30265-6 · ExternalCitation · doi-reference

The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

10.1016/s2468-1253(19)30333-4 · ExternalCitation · doi-reference

C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and meta-analysis

10.1038/ajg.2015.120 · ExternalCitation · doi-reference

Biomarkers in search of precision medicine in IBD

10.1038/ajg.2016.441 · ExternalCitation · doi-reference

Loss of response to anti-TNFs: definition, epidemiology, and management

10.1038/ctg.2015.63 · ExternalCitation · doi-reference

Single-cell chromatin accessibility reveals principles of regulatory variation

10.1038/nature14590 · ExternalCitation · doi-reference

A single-cell survey of the small intestinal epithelium

10.1038/nature24489 · ExternalCitation · doi-reference

Massively parallel digital transcriptional profiling of single cells

10.1038/ncomms14049 · ExternalCitation · doi-reference

In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease

10.1038/nm.3462 · ExternalCitation · doi-reference

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease

10.1038/nm.4307 · ExternalCitation · doi-reference

Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry

10.1038/nmeth.2869 · ExternalCitation · doi-reference

Simultaneous epitope and transcriptome measurement in single cells

10.1038/nmeth.4380 · ExternalCitation · doi-reference

Immunopathogenesis of IBD: current state of the art

10.1038/nrgastro.2015.186 · ExternalCitation · doi-reference

Current and emerging therapeutic targets for IBD

10.1038/nrgastro.2016.208 · ExternalCitation · doi-reference

Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification

10.1038/s41467-019-10769-x · ExternalCitation · doi-reference

Inference and analysis of cell-cell communication using CellChat

10.1038/s41467-021-21246-9 · ExternalCitation · doi-reference

Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions

10.1038/s41467-021-22164-6 · ExternalCitation · doi-reference

Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease

10.1038/s41467-021-24470-5 · ExternalCitation · doi-reference

Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease

10.1038/s41467-023-40156-6 · ExternalCitation · doi-reference

High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis

10.1038/s41467-023-43458-x · ExternalCitation · doi-reference

Single-cell and spatial multi-omics highlight effects of anti-integrin therapy across cellular compartments in ulcerative colitis

10.1038/s41467-024-45665-6 · ExternalCitation · doi-reference

Identification and multimodal characterization of a specialized epithelial cell type associated with Crohn's disease

10.1038/s41467-024-51580-7 · ExternalCitation · doi-reference

A multi-omics spatial framework for host-microbiome dissection within the intestinal tissue microenvironment

10.1038/s41467-025-56237-7 · ExternalCitation · doi-reference

Systematic benchmarking of imaging spatial transcriptomics platforms in FFPE tissues

10.1038/s41467-025-64990-y · ExternalCitation · doi-reference

Patient-derived colon epithelial organoids reveal lipid-related metabolic dysfunction in pediatric ulcerative colitis

10.1038/s41467-025-65988-2 · ExternalCitation · doi-reference

Spatial transcriptomics atlas of inflammatory bowel disease to guide implementation in research consortiums and clinical trials

10.1038/s41467-026-72482-w · ExternalCitation · doi-reference

Human inflammatory bowel disease-on-a-chip for modelling disease progression, cancer initiation and sex-specific effects

10.1038/s41551-026-01686-8 · ExternalCitation · doi-reference

Revisiting fibrosis in inflammatory bowel disease: the gut thickens

10.1038/s41575-021-00543-0 · ExternalCitation · doi-reference

Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics

10.1038/s41576-021-00370-8 · ExternalCitation · doi-reference

Allergic inflammatory memory in human respiratory epithelial progenitor cells

10.1038/s41586-018-0449-8 · ExternalCitation · doi-reference

Colonic epithelial cell diversity in health and inflammatory bowel disease

10.1038/s41586-019-0992-y · ExternalCitation · doi-reference

Transcriptome-scale super-resolved imaging in tissues by RNA seqFISH+

10.1038/s41586-019-1049-y · ExternalCitation · doi-reference

Somatic inflammatory gene mutations in human ulcerative colitis epithelium

10.1038/s41586-019-1844-5 · ExternalCitation · doi-reference

Pathway paradigms revealed from the genetics of inflammatory bowel disease

10.1038/s41586-020-2025-2 · ExternalCitation · doi-reference

Highly multiplexed spatial mapping of microbial communities

10.1038/s41586-020-2983-4 · ExternalCitation · doi-reference

Exploring tissue architecture using spatial transcriptomics

10.1038/s41586-021-03634-9 · ExternalCitation · doi-reference

Cells of the human intestinal tract mapped across space and time

10.1038/s41586-021-03852-1 · ExternalCitation · doi-reference

Single-cell integration reveals metaplasia in inflammatory gut diseases

10.1038/s41586-024-07571-1 · ExternalCitation · doi-reference

Human organoids with an autologous tissue-resident immune compartment

10.1038/s41586-024-07791-5 · ExternalCitation · doi-reference

Spatial fibroblast niches define Crohn's fistulae

10.1038/s41586-025-09744-y · ExternalCitation · doi-reference

Multiplex digital spatial profiling of proteins and RNA in fixed tissue

10.1038/s41587-020-0472-9 · ExternalCitation · doi-reference

Robust decomposition of cell type mixtures in spatial transcriptomics

10.1038/s41587-021-00830-w · ExternalCitation · doi-reference

Cell segmentation in imaging-based spatial transcriptomics

10.1038/s41587-021-01044-w · ExternalCitation · doi-reference

Cell2location maps fine-grained cell types in spatial transcriptomics

10.1038/s41587-021-01139-4 · ExternalCitation · doi-reference

High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging

10.1038/s41587-022-01483-z · ExternalCitation · doi-reference

Standardized metrics for assessment and reproducibility of imaging-based spatial transcriptomics datasets

10.1038/s41587-025-02811-9 · ExternalCitation · doi-reference

Single-cell and spatial transcriptomics of stricturing Crohn's disease highlights a fibrosis-associated network

10.1038/s41588-025-02225-y · ExternalCitation · doi-reference

Distinct microbial and immune niches of the human colon

10.1038/s41590-020-0602-z · ExternalCitation · doi-reference

Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis

10.1038/s41590-022-01312-0 · ExternalCitation · doi-reference

A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease

10.1038/s41590-024-01994-8 · ExternalCitation · doi-reference

Single-cell atlas of colonic CD8+ T cells in ulcerative colitis

10.1038/s41591-020-1003-4 · ExternalCitation · doi-reference

IL-1-driven stromal-neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies

10.1038/s41591-021-01520-5 · ExternalCitation · doi-reference

Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity

10.1038/s41591-022-01680-y · ExternalCitation · doi-reference

Deep generative modeling for single-cell transcriptomics

10.1038/s41592-018-0229-2 · ExternalCitation · doi-reference

High-definition spatial transcriptomics for in situ tissue profiling

10.1038/s41592-019-0548-y · ExternalCitation · doi-reference

Fast, sensitive and accurate integration of single-cell data with Harmony

10.1038/s41592-019-0619-0 · ExternalCitation · doi-reference

NicheNet: modeling intercellular communication by linking ligands to target genes

10.1038/s41592-019-0667-5 · ExternalCitation · doi-reference

Method of the Year: spatially resolved transcriptomics

10.1038/s41592-020-01033-y · ExternalCitation · doi-reference

Deep learning and alignment of spatially resolved single-cell transcriptomes with Tangram

10.1038/s41592-021-01264-7 · ExternalCitation · doi-reference

Squidpy: a scalable framework for spatial omics analysis

10.1038/s41592-021-01358-2 · ExternalCitation · doi-reference

Museum of spatial transcriptomics

10.1038/s41592-022-01409-2 · ExternalCitation · doi-reference

SpatialData: an open and universal data framework for spatial omics

10.1038/s41592-024-02212-x · ExternalCitation · doi-reference

Systematic comparison of sequencing-based spatial transcriptomic methods

10.1038/s41592-024-02325-3 · ExternalCitation · doi-reference

CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand–receptor complexes

10.1038/s41596-020-0292-x · ExternalCitation · doi-reference

Development of a human primary gut-on-a-chip to model inflammatory processes

10.1038/s41598-020-78359-2 · ExternalCitation · doi-reference

The FAIR Guiding Principles for scientific data management and stewardship

10.1038/sdata.2016.18 · ExternalCitation · doi-reference

Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease

10.1053/j.gastro.2015.02.031 · ExternalCitation · doi-reference

Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases

10.1053/j.gastro.2016.09.047 · ExternalCitation · doi-reference

HLA-DQA1*05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn's disease

10.1053/j.gastro.2019.09.041 · ExternalCitation · doi-reference

STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease initiative of the International Organization for the Study of IBD

10.1053/j.gastro.2020.12.031 · ExternalCitation · doi-reference

Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension

10.1053/j.gastro.2021.08.053 · ExternalCitation · doi-reference

How do we predict a patient's disease course and whether they will respond to specific treatments

10.1053/j.gastro.2021.12.245 · ExternalCitation · doi-reference

Artificial intelligence enabled histological prediction of remission or activity and clinical outcomes in ulcerative colitis

10.1053/j.gastro.2023.02.031 · ExternalCitation · doi-reference

Stricturing Crohn's disease single-cell RNA sequencing reveals fibroblast heterogeneity and intercellular interactions

10.1053/j.gastro.2023.07.014 · ExternalCitation · doi-reference

AGA living clinical practice guideline on pharmacological management of moderate-to-severe ulcerative colitis

10.1053/j.gastro.2024.10.001 · ExternalCitation · doi-reference

Infliximab for induction and maintenance therapy for ulcerative colitis

10.1056/nejmoa050516 · ExternalCitation · doi-reference

Vedolizumab as induction and maintenance therapy for ulcerative colitis

10.1056/nejmoa1215734 · ExternalCitation · doi-reference

Vedolizumab as induction and maintenance therapy for Crohn's disease

10.1056/nejmoa1215739 · ExternalCitation · doi-reference

Ustekinumab as induction and maintenance therapy for Crohn's disease

10.1056/nejmoa1602773 · ExternalCitation · doi-reference

Tofacitinib as induction and maintenance therapy for ulcerative colitis

10.1056/nejmoa1606910 · ExternalCitation · doi-reference

Vedolizumab versus adalimumab for moderate-to-severe ulcerative colitis

10.1056/nejmoa1905725 · ExternalCitation · doi-reference

Ozanimod as induction and maintenance therapy for ulcerative colitis

10.1056/nejmoa2033617 · ExternalCitation · doi-reference

Mirikizumab as induction and maintenance therapy for ulcerative colitis

10.1056/nejmoa2207940 · ExternalCitation · doi-reference

Upadacitinib induction and maintenance therapy for Crohn's disease

10.1056/nejmoa2212728 · ExternalCitation · doi-reference

Phase 2 trial of anti-TL1A monoclonal antibody tulisokibart for ulcerative colitis

10.1056/nejmoa2314076 · ExternalCitation · doi-reference

Pathophysiology of inflammatory bowel diseases

10.1056/nejmra2002697 · ExternalCitation · doi-reference

Spatial transcriptome profiling by MERFISH reveals subcellular RNA compartmentalization and cell cycle-dependent gene expression

10.1073/pnas.1912459116 · ExternalCitation · doi-reference

ECCO Guidelines on Therapeutics in Ulcerative Colitis: medical treatment

10.1093/ecco-jcc/jjab178 · ExternalCitation · doi-reference

Deep learning models capture histological disease activity in Crohn’s disease and ulcerative colitis with high fidelity

10.1093/ecco-jcc/jjad171 · ExternalCitation · doi-reference

ECCO Guidelines on Therapeutics in Crohn's Disease: medical treatment

10.1093/ecco-jcc/jjae091 · ExternalCitation · doi-reference

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications

10.1093/ecco-jcc/jjaf106 · ExternalCitation · doi-reference

Spatial transcriptomics reveals unique inflammatory signatures across all anatomic locations in postoperative Crohn's disease

10.1093/ecco-jcc/jjaf180 · ExternalCitation · doi-reference

Selective IL-23 inhibition by risankizumab modulates the molecular profile in the colon and ileum of patients with active Crohn's disease: results from a randomised phase II biopsy sub-study

10.1093/ecco-jcc/jjy099 · ExternalCitation · doi-reference

Predictors of primary response to biologic treatment [anti-TNF, vedolizumab, and ustekinumab] in patients with inflammatory bowel disease: from basic science to clinical practice

10.1093/ecco-jcc/jjz195 · ExternalCitation · doi-reference

Oncostatin M is a biomarker of diagnosis, worse disease prognosis, and therapeutic nonresponse in inflammatory bowel disease

10.1093/ibd/izab032 · ExternalCitation · doi-reference

Challenges in IBD research 2024: precision medicine

10.1093/ibd/izae084 · ExternalCitation · doi-reference

An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease

10.1111/apt.14853 · ExternalCitation · doi-reference

A tissue atlas of ulcerative colitis revealing evidence of sex-dependent differences in disease-driving inflammatory cell types and resistance to TNF inhibitor therapy

10.1126/sciadv.add1166 · ExternalCitation · doi-reference

RNA imaging. Spatially resolved, highly multiplexed RNA profiling in single cells

10.1126/science.aaa6090 · ExternalCitation · doi-reference

Visualization and analysis of gene expression in tissue sections by spatial transcriptomics

10.1126/science.aaf2403 · ExternalCitation · doi-reference

Slide-seq: a scalable technology for measuring genome-wide expression at high spatial resolution

10.1126/science.aaw1219 · ExternalCitation · doi-reference

Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses

10.1126/sciimmunol.abb4432 · ExternalCitation · doi-reference

Gut-associated lymphoid tissue attrition associates with response to anti-alpha4beta7 therapy in ulcerative colitis

10.1126/sciimmunol.adg7549 · ExternalCitation · doi-reference

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

10.1136/gut.2009.178665 · ExternalCitation · doi-reference

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

10.1136/gutjnl-2011-301668 · ExternalCitation · doi-reference

Mucosal healing in inflammatory bowel diseases: a systematic review

10.1136/gutjnl-2012-302830 · ExternalCitation · doi-reference

Development and validation of a histological index for UC

10.1136/gutjnl-2015-310393 · ExternalCitation · doi-reference

Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis

10.1136/gutjnl-2016-312609 · ExternalCitation · doi-reference

Cell-centred meta-analysis reveals baseline predictors of anti-TNFalpha non-response in biopsy and blood of patients with IBD

10.1136/gutjnl-2017-315494 · ExternalCitation · doi-reference

Immunopathogenesis of chronic rhinosinusitis and nasal polyposis

10.1146/annurev-pathol-052016-100401 · ExternalCitation · doi-reference

Altered inflammatory mucosal signatures within their spatial and cellular context during active ileal Crohn's disease

10.1172/jci.insight.171783 · ExternalCitation · doi-reference

VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease

10.1172/jci72189 · ExternalCitation · doi-reference

SCANPY: large-scale single-cell gene expression data analysis

10.1186/s13059-017-1382-0 · ExternalCitation · doi-reference

Giotto: a toolbox for integrative analysis and visualization of spatial expression data

10.1186/s13059-021-02286-2 · ExternalCitation · doi-reference

An introduction to spatial transcriptomics for biomedical research

10.1186/s13073-022-01075-1 · ExternalCitation · doi-reference

Validation and optimization of an ex vivo assay of intestinal mucosal biopsies in Crohn's disease: reflects inflammation and drug effects

10.1371/journal.pone.0155335 · ExternalCitation · doi-reference

Patient-derived organoids for therapy personalization in inflammatory bowel diseases

10.3748/wjg.v28.i24.2636 · ExternalCitation · doi-reference

Comparative analysis of multiplexed in situ gene expression profiling technologies

10.7554/elife.96949 · ExternalCitation · doi-reference